GlassScriptPhysician profile
Walter W Costner
NPI 1417993957
$3,615.12
in general payments reported to CMS, 2019-2025
56 companies · $910 in 2025
The $910 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $467 · 2020: $229 · 2021: $579 · 2022: $285 · 2023: $503 · 2024: $641 · 2025: $910.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,684 · Long Term Medical Supply Or Device Loan: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,684.03 |
| Long Term Medical Supply Or Device Loan | $370.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $429.05 | 2020-2025 | Qulipta, Ubrelvy, Vraylar |
| Pentax of America, INC. | $370.36 | 2025 | Pentax Medical, Sony |
| Teva Pharmaceuticals USA, INC. | $282.41 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $242.06 | 2023-2025 | Caplyta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $240.70 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Amgen INC. | $159.54 | 2019-2024 | Repatha, Otezla |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $153.16 | 2019-2025 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $111.13 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $85.50 | 2024-2025 | |
| Genzyme Corporation | $82.53 | 2025 | |
| Novo Nordisk INC | $82.03 | 2019-2024 | Wegovy |
| Medtronic, INC. | $65.41 | 2022-2023 | Nexpowder |
| Organogenesis INC. | $65.39 | 2019-2021 | |
| Acera Surgical, INC. | $62.31 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $61.77 | 2020-2021 |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $54.40 | 2022-2025 | Dexcom G6 Transmitter |
| Daiichi Sankyo INC. | $53.74 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $49.54 | 2020-2023 | Breztri |
| Smith+Nephew, INC. | $47.15 | 2019-2020 | |
| Lilly USA, LLC | $46.85 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $44.41 | 2019-2022 | |
| Qol Medical, LLC | $42.44 | 2025 | Sucraid |
| Almatica Pharma LLC | $39.28 | 2021 | |
| Kerecis Limited | $39.14 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Otsuka America Pharmaceutical, INC. | $36.24 | 2022-2024 | Rexulti |
| Biohaven Pharmaceuticals, INC. | $34.02 | 2021 | |
| Amarin Pharma, INC. | $33.32 | 2021 | |
| Abbott Laboratories | $32.10 | 2021-2024 | Freestyle Libre 3 |
| Lundbeck LLC | $30.65 | 2025 | Rexulti |
| Ferring Pharmaceuticals INC. | $30.17 | 2023 | Clenpiq |
| Boston Scientific Corporation | $29.99 | 2019-2020 | |
| Integra Lifesciences Corporation | $29.92 | 2019 | |
| Glaxosmithkline, LLC. | $29.09 | 2025 | Trelegy Ellipta |
| Genentech USA, INC. | $27.36 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $27.14 | 2022-2023 | Seglentis, Livalo |
| Eisai INC. | $24.81 | 2020-2021 | |
| Olympus America INC. | $24.56 | 2023 | Endoclot Phs |
| Janssen Biotech, INC. | $24.30 | 2025 | Tremfya |
| Stryker Corporation | $24.13 | 2025 | Gamma, Variax |
| Melinta Therapeutics, LLC | $22.74 | 2019 | |
| Sumitomo Pharma America, INC. | $20.90 | 2025 | Gemtesa |
| Portola Pharmaceuticals, LLC | $20.45 | 2019 | |
| Heron Therapeutics, INC. | $17.76 | 2024 | Aponvie |
| Medtronic Minimed, INC. | $17.52 | 2019 | |
| Ibsa Pharma INC. | $17.20 | 2023 | Tirosint, Licart |
| Exeltis, USA INC. | $16.99 | 2021 | |
| Lifenet Health | $16.83 | 2024 | Theragenesis Wound Matrix |
| Neurocrine Biosciences, INC. | $15.52 | 2020 | |
| Esperion Therapeutics, INC. | $13.73 | 2020 | |
| Exact Sciences Corporation | $13.56 | 2025 | The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $13.50 | 2025 | |
| Sanofi Pasteur INC. | $12.92 | 2019 | |
| Agile Therapeutics, INC. | $12.48 | 2021 | |
| Covidien LP | $12.02 | 2019 | |
| Shire North American Group INC | $11.78 | 2019 | |
| Tela Bio, INC. | $11.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Costner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.